|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| |||
|
a)
|
Name
|
Mr R G Connor
| ||
|
b)
|
Position/status
|
President, Global Manufacturing & Supply
| ||
|
c)
|
Initial notification/
amendment
|
Initial notification
| ||
|
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||
|
a)
|
Name
|
GlaxoSmithKline plc
| ||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
| ||
|
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| |||
|
a)
|
Description of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
| ||
|
b)
|
Nature of the transaction
|
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016 on Ordinary Shares held in the Company's 2009 Performance Share Plan.
| ||
|
c)
|
Price(s) and
volume(s)
|
Price(s)
|
Volume(s)
|
|
|
£16.285
|
1,075.877
| |||
|
£16.285
|
1,103.139
| |||
|
£16.285
|
1,412.935
| |||
|
d)
|
Aggregated information
|
| ||
|
|
Aggregated volume
|
3,591.951
| ||
|
|
Price
|
£16.285
| ||
|
e)
|
Date of the transaction
|
2016-07-14
| ||
|
f)
|
Place of the transaction
|
n/a
| ||